Advances in Psychiatry and Neurology
eISSN: 2720-5371
ISSN: 1230-2813
Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii
Current issue Archive Manuscripts accepted About the journal Scientific board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Share:
Share:
Original paper

Depression, trauma, stressful life events and childhood infections in patients with multiple sclerosis in the Polish population – a case-control study

Katarzyna Rosiak
,
Przemysław M. Waszak
,
Magdalena Pierucka
,
Dorota Dydjow-Bendek
,
Paweł Zagożdżon
,
Katarzyna Trzeciak-Bilska
,
Ewa Knitter

Adv Psychiatry Neurol 2026; 35 (1): 19-27
Online publish date: 2026/03/04
Article file
Get citation
 
PlumX metrics:
 
1. Dobson R, Giovannoni G. Multiple sclerosis – a review. Eur J Neurol 2019; 26: 27-40.
2. Artemiadis AK, Anagnostouli MC, Alexopoulos EC. Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology 2011; 36: 109-120.
3. Young CA, Langdon D, Rog D, Chhetri SK, Tanasescu R, Kalra S, et al. Prevalence, treatment and correlates of depression in multiple sclerosis. Mult Scler Relat Disord 2024; 87: 105648. DOI: https://doi.org/10.1016/j.msard.2024.105648.
4. Kim S, Foley FW, Picone MA, Halper J, Zemon V. Depression levels and interferon treatment in people with multiple sclerosis. Int J MS Care 2012; 14: 10-16.
5. Bazmi E, Behnoush AH, Eskandarieh S, Moghadasi AN, Navardi S, Ayoubi S, et al. Suicidal ideation in patients with multiple sclerosis and its association with clinical and demographic characteristics. Brain Behav 2025; 15: e70458. DOI: https://doi.org/10.1002/brb3.70458.
6. von Drathen S, Gold SM, Peper J, Rahn AC, Ramien C, Magyari M, et al. Stress and multiple sclerosis – systematic review and meta-analysis of the association with disease onset, relapse risk and disability progression. Brain Behav Immun 2024; 120: 620-629.
7. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347: 911-920.
8. Bjornevik K, Münz C, Cohen JI, Ascherio A. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat Rev Neurol 2023; 19: 160-171.
9. Jacobs BM, Giovannoni G, Cuzick J, Dobson R. Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors. Mult Scler Houndmills Basingstoke Engl 2020; 26: 1281-1297.
10. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
11. Sobolewski A, Strelau J, Zwadzki B. Kwestionariusz Zmian Życiowych (KZŻ): Polska adaptacja kwestionariusza „Recent Life Changes Questionnaire” (RLCQ) R. H. Rahe’a. Przegląd Psychologiczny 1999; 42: 27-49.
12. Patten SB, Marrie RA, Carta MG. Depression in multiple sclerosis. Int Rev Psychiatry Abingdon Engl 2017; 29: 463-472.
13. Boeschoten RE, Braamse AMJ, Beekman ATF, Cuijpers P, van Oppen P, Dekker J, et al. Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci 2017; 372: 331-341.
14. Koch MW, Patten S, Berzins S, Zhornitsky S, Greenfield J, Wall W, et al. Depression in multiple sclerosis: a long-term longitudinal study. Mult Scler Houndmills Basingstoke Engl 2015; 21: 76-82.
15. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 2002; 159: 1862-1868.
16. Martinelli V. Trauma, stress and multiple sclerosis. Neurol Sci 2000; 21 (4 Suppl 2): S849-S852. DOI: https://doi.org/10.1007/s100720070024.
17. Braley TJ, Chervin RD. Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment. Sleep 2010; 33: 1061-1067.
18. Brola W, Szcześniak M, Wilski M, Żak M, Sobolewski P, Wnuk M, et al. Sense of happiness in Polish patients with multiple sclerosis. Neurol Neurochir Pol 2023; 57: 484-491.
19. Filippi M, Rovaris M, Inglese M, Barkhof F, De Stefano N, Smith S, et al. Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Lond Engl 2004; 364: 1489-1496.
20. Brenner P, Burkill S, Jokinen J, Hillert J, Bahmanyar S, Montgomery S. Multiple sclerosis and risk of attempted and completed suicide – a cohort study. Eur J Neurol 2016; 23: 1329-1336.
21. Feinstein A. Multiple sclerosis and depression. Mult Scler Houndmills Basingstoke Engl 2011; 17: 1276-1281.
22. Sironi M, Clerici M. The hygiene hypothesis: an evolutionary perspective. Microbes Infect 2010; 12: 421-427.
23. Ehlers S, Kaufmann SHE, Participants of the 99(th) Dahlem Conference. Infection, inflammation, and chronic diseases: consequences of a modern lifestyle. Trends Immunol 2010; 31: 184-190.
24. Wendel-Haga M, Celius EG. Is the hygiene hypothesis relevant for the risk of multiple sclerosis? Acta Neurol Scand 2017; 136 Suppl 201: 26-30. DOI: https://doi.org/10.1111/ane.12844.
25. Bloomfield SF, Rook GA, Scott EA, Shanahan F, Stanwell-Smith R, Turner P. Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene. Perspect Public Health 2016; 136: 213-224.
26. Jiang X, Olsson T, Hillert J, Kockum I, Alfredsson L. Stressful life events are associated with the risk of multiple sclerosis. Eur J Neurol 2020; 27: 2539-2548.
27. Abdollahpour I, Nedjat S, Mansournia MA, Eckert S, Weinstock-Guttman B. Stress-full life events and multiple sclerosis: a population-based incident case-control study. Mult Scler Relat Disord 2018; 26: 168-172.
28. Kroencke DC, Denney DR. Stress and coping in multiple sclerosis: exacerbation, remission and chronic sub­groups. Mult Scler Houndmills Basingstoke Engl 1999; 5: 89-93.
29. Topp J, Andrees V, Heesen C, Augustin M, Blome C. Recall of health-related quality of life: how does memory affect the SF-6D in patients with psoriasis or multiple sclerosis? A prospective observational study in Germany. BMJ Open 2019; 9: e032859. DOI: https://doi.org/10.1136/bmjopen-2019-032859.
30. Gich J, Salavedra-Pont J, Coll-Martinez C, Quintana E, Álvarez-Bravo G, Robles-Cedeño R, et al. The nature of memory impairment in multiple sclerosis: understanding different patterns over the course of the disease. Front Psychol 2023; 14: 1269794. DOI: https://doi.org/10.3389/fpsyg.2023.1269794.
31. Lutsey PL. Case-control studies: Increasing scientific rigor in control selection. Res Pract Thromb Haemost 2023; 7: 100090. DOI: https://doi.org/10.1016/j.rpth.2023.100090.
32. Patterson AL, Morasco BJ, Fuller BE, Indest DW, Loftis JM, Hauser P. Screening for depression in patients with hepatitis C using the Beck Depression Inventory-II: do somatic symptoms compromise validity? Gen Hosp Psychiatry 2011; 33: 354-262.
33. Thombs BD, Ziegelstein RC, Pilote L, Dozois DJA, Beck AT, Dobson KS, et al. Somatic symptom overlap in Beck Depression Inventory-II scores following myocardial infarction. Br J Psychiatry J Ment Sci 2010; 197: 61-66.
34. Wang YP, Gorenstein C. Assessment of depression in medical patients: a systematic review of the utility of the Beck Depression Inventory-II. Clinics 2013; 68: 1274-1287.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0). License allowing third parties to download and share its works but not commercially purposes or to create derivative works.
Quick links
© 2026 Termedia Sp. z o.o.
Developed by Termedia.